These key additions will guide AllazoHealth as it scales product development to support pharma companies with AI-powered personalization technology

AllazoHealth Appoints Three New Advisory Board Members Amid Product Expansions

Media Contact:
Hilary McCarthy
774.364.1440
hilary@fordhutmanmedia.com

AllazoHealth, the pioneer in driving therapy initiation, adherence, and health outcomes with artificial intelligence (AI)-powered personalization, today announced that Joy S. Neely, Nagaraja Srivatsan, and Kenneth Ziegler have joined its advisory board. The three executives have extensive backgrounds in life sciences, technology, and enterprise growth strategies, and will provide valuable insights to AllazoHealth as the company initiates plans for product expansions and growth.

The three new advisors will join Mark Degatano, who has advised AllazoHealth since 2019, and has served as an advisor to Medicx Health, Verix, and ViiHealth.

Joy S. Neely is Chief Commercial Officer at Medvantx, where she leads sales and marketing for the non-commercial dispensing pharmacy services provider. Formerly she was Senior Vice President of Sales for Caremetx, a technology-enabled patient services partner, and held senior-level roles at Roche Diagnostics, Mercalis, and Lilly USA in the latter’s Oncology and Diabetes divisions.

Nagaraja Srivatsan has 30+ years of experience leading businesses in digital, data, AI, and analytics. As founder of Vidya Seva, he helps startups scale. Previously, he was Chief Digital Officer for R&DS Technologies at IQVIA, responsible for driving growth, product development and operations, and was Chief Growth Officer for EXL, a data analytics and digital transformation provider. He was SVP & Chief Digital Officer Healthcare at Cognizant, responsible for growing its life sciences business to a tier-one provider. Srivatsan has worked with top 50 global life sciences organizations to transform their businesses and was recognized in the top 100 most inspiring people in life sciences by PharmaVOICE.

Kenneth Ziegler is a growth-focused private equity (PE) CEO/operator with 20+ years of experience in tech-enabled services and infrastructure software. Ziegler successfully led Logicworks through two PE investment cycles and into new markets as a pioneering Cloud Automation and Managed Services Premier Partner of AWS and Azure, resulting in a strategic acquisition by Cox Communications in 2023. Today, Ziegler helps investors, entrepreneurs, and their operating companies with leadership team formation and development, GTM industrialization, and other components of value creation specific to their phase of growth.

“Consumers want an active role in their healthcare, but need communications that speak to them. AllazoHealth’s proven technology optimizes patient communications by personalizing the patient’s experience – delivering measurable results across therapeutic areas,” says Joy S. Neely, Chief Commercial Officer at Medvantx. “By leveraging AI and years of industry experience, AllazoHealth enables pharma companies to successfully reach individual patients and encourage them to initiate prescribed medications and stick to them. I’m honored to be part of AllazoHealth’s journey as it significantly improves communications between pharma companies and healthcare consumers to improve health outcomes.”

AllazoHealth CEO William Grambley agrees and says these renowned industry professionals will be instrumental as the company expands in pharma and develops more products that seamlessly personalize communications to patients at scale.

“The potential for AllazoHealth to further help pharmaceutical companies, providers, and patients improve medication initiation, long-term adherence, and health outcomes with AI-powered personalization and data analytics is vast,” says Grambley. “We look forward to leveraging the deep industry and business expertise of our advisory board as we continue to expand on our technological offerings and grow AllazoHealth.”

About AllazoHealth

AllazoHealth is the pioneer driving therapy initiation, adherence, and health outcomes with AI-powered personalization. The technology optimizes patient programs by personalizing their experience. It has proven results across therapeutic areas from mass market to specialty and rare disease therapies. Using identified patient data and predictive AI, AllazoHealth creates the optimal engagement for each patient by personalizing every communication. AllazoHealth targets the right patients with the right message at the right time via the right channels - at scale - maximizing the impact and efficiency of pharmaceutical patient marketing and patient support programs. Built within Microsoft Azure, the platform is fully HIPAA compliant and HITRUST certified. AllazoHealth is named in PM360's Innovation Issue and is the winner of the FiercePharma Innovation Award. Learn more at https://allazohealth.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241015159907/en/